Cargando...
Engineering therapeutic antibodies to combat infectious diseases
Serum therapy fell out of favor 80 years ago, but antibodies against infectious diseases are now experiencing a renaissance. With the evolution of antibiotic-resistant bacteria, the emergence of new pathogens, and a growing population of immunocompromised individuals coupled with improvements in ant...
Gardado en:
| Publicado en: | Curr Opin Chem Eng |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5998816/ https://ncbi.nlm.nih.gov/pubmed/29911002 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coche.2018.01.007 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|